Document is current
Any future updates will be listed below
-
Authors
Brettmann, Erin
Chen, Fuqiang
Beishir, Stephen
Garvey, Graeme
- License Information
-
More Information
Article History
Received: 13 June 2025
Accepted: 4 August 2025
First Online: 29 August 2025
Declarations
:
: Not applicable.
: Not applicable.
: All authors are current or former employees of Merck KGaA, Darmstadt, Germany, known in the United States and Canada as MilliporeSigma. The work detailed in this report has been filed as patent applications PCT/US2023/082569, PCT/US2025/029391, and PCT/US2025/019516. PEXBUFF transfection enhancer is covered by PCT/US2022/079037.
